LVRNA010
/ AIM Vaccine
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 31, 2022
Clinical Study of SARS-CoV-2 Variant mRNA Vaccine in Healthy Participants
(clinicaltrials.gov)
- P1 | N=144 | Not yet recruiting | Sponsor: AIM Vaccine Co., Ltd.
New P1 trial • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1